- Home
- CPNG vs TAK Comparison
CPNG vs TAK Comparison
Compare CPNG & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPNG
- TAK
- Stock Information
- Founded
- CPNG 2010
- TAK 1781
- Country
- CPNG United States
- TAK Japan
- Employees
- CPNG N/A
- TAK N/A
- Industry
- CPNG Durable Goods
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- CPNG Consumer Discretionary
- TAK Health Care
- Exchange
- CPNG Nasdaq
- TAK Nasdaq
- Market Cap
- CPNG 45.6B
- TAK 43.9B
- IPO Year
- CPNG 2021
- TAK N/A
- Fundamental
- Price
- CPNG $24.48
- TAK $13.63
- Analyst Decision
- CPNG Strong Buy
- TAK
- Analyst Count
- CPNG 9
- TAK 0
- Target Price
- CPNG $27.00
- TAK N/A
- AVG Volume (30 Days)
- CPNG 9.5M
- TAK 1.3M
- Earning Date
- CPNG 11-05-2024
- TAK 10-31-2024
- Dividend Yield
- CPNG N/A
- TAK 4.65%
- EPS Growth
- CPNG 138.42
- TAK 49.73
- EPS
- CPNG 0.57
- TAK 1.27
- Revenue
- CPNG $28,864,000,000.00
- TAK $31,732,209,416.00
- Revenue This Year
- CPNG $27.24
- TAK $4.41
- Revenue Next Year
- CPNG $17.32
- TAK $1.09
- P/E Ratio
- CPNG $42.86
- TAK $21.56
- Revenue Growth
- CPNG 24.69
- TAK 9.43
- 52 Week Low
- CPNG $13.51
- TAK $12.58
- 52 Week High
- CPNG $26.91
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- CPNG 46.15
- TAK 39.22
- Support Level
- CPNG $23.62
- TAK $13.46
- Resistance Level
- CPNG $26.08
- TAK $13.75
- Average True Range (ATR)
- CPNG 0.88
- TAK 0.16
- MACD
- CPNG -0.12
- TAK -0.01
- Stochastic Oscillator
- CPNG 38.51
- TAK 21.15
About CPNG Coupang Inc.
Coupang Inc is an e-commerce company. It sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Developing Offerings. The company generates maximum revenue from the Product Commerce segment. Product Commerce includes core retail (owned inventory) and marketplace offerings (third-party merchants) and Rocket Fresh, fresh grocery offering, as well as advertising products associated with these offerings.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.